Reduction of hair growth

Details Reduction of hair growth Reduction of hair growth

2008-03-18

2008-03-18

Puttlitz, Karl (Department: 1621)

Organic compounds -- part of the class 532-570 series

Organic compounds

Carboxylic acid esters

C560S206000, C560S226000, C514S740000

Reexamination Certificate

active

11272250

ABSTRACT:
Compositions including a conjugate of α-difluoromethylornithine can be applied topically to reduce hair growth.

REFERENCES:
patent: 3426137 (1969-02-01), Philpitt et al.
patent: 4039669 (1977-08-01), Beyler et al.
patent: 4139638 (1979-02-01), Neri et al.
patent: 4161540 (1979-07-01), Neri et al.
patent: 4191775 (1980-03-01), Glen
patent: 4269831 (1981-05-01), Ferrari et al.
patent: 4370315 (1983-01-01), Greff et al.
patent: 4508714 (1985-04-01), Cecic et al.
patent: 4517175 (1985-05-01), Iwabuchi et al.
patent: 4720489 (1988-01-01), Shander
patent: 4885289 (1989-12-01), Breuer et al.
patent: 4935231 (1990-06-01), Pigiet
patent: 5095007 (1992-03-01), Ahluwalia
patent: 5096911 (1992-03-01), Ahluwalia et al.
patent: 5132293 (1992-07-01), Shander et al.
patent: 5143925 (1992-09-01), Shander et al.
patent: 5189212 (1993-02-01), Ruenitz
patent: 5271942 (1993-12-01), Heverhagen
patent: 5300284 (1994-04-01), Wiechers et al.
patent: 5328686 (1994-07-01), Shander et al.
patent: 5362748 (1994-11-01), Schwen et al.
patent: 5364885 (1994-11-01), Ahluwalia et al.
patent: 5411991 (1995-05-01), Shander et al.
patent: 5444090 (1995-08-01), Ahluwalia
patent: 5455234 (1995-10-01), Ahluwalia et al.
patent: 5468476 (1995-11-01), Ahluwalia et al.
patent: 5474763 (1995-12-01), Shander et al.
patent: 5554608 (1996-09-01), Ahluwalia et al.
patent: 5645825 (1997-07-01), Hillebrand et al.
patent: 5648394 (1997-07-01), Boxall et al.
patent: 5652273 (1997-07-01), Henry et al.
patent: 5674477 (1997-10-01), Ahluwalia
patent: 5728736 (1998-03-01), Shander et al.
patent: 5776442 (1998-07-01), Ahluwalia
patent: 5824665 (1998-10-01), Henry et al.
patent: 5840752 (1998-11-01), Henry et al.
patent: 5908867 (1999-06-01), Henry et al.
patent: 5939458 (1999-08-01), Henry et al.
patent: 5958946 (1999-09-01), Styczynski et al.
patent: 5962466 (1999-10-01), Styczynski et al.
patent: 6020006 (2000-02-01), Styczynski et al.
patent: 6037326 (2000-03-01), Styczynski et al.
patent: 6060471 (2000-05-01), Styczynski et al.
patent: 6093748 (2000-07-01), Ahluwalia et al.
patent: 6121269 (2000-09-01), Henry et al.
patent: 6218435 (2001-04-01), Henry et al.
patent: 6235737 (2001-05-01), Styczynski et al.
patent: 6239170 (2001-05-01), Ahluwalia et al.
patent: 6248751 (2001-06-01), Ahluwalia et al.
patent: 6284234 (2001-09-01), Niemiec et al.
patent: 6299865 (2001-10-01), Styczynski et al.
patent: 2003/0053973 (2003-03-01), Chou et al.
patent: 881 208 (1980-06-01), None
patent: 0 532 219 (1992-09-01), None
patent: 1 458 349 (1976-12-01), None
patent: WO 98/02134 (1998-01-01), None
patent: WO 98/14188 (1998-04-01), None
patent: WO 01/68076 (2001-09-01), None
patent: WO 02/086138 (2002-10-01), None
patent: WO 03/013496 (2003-02-01), None
patent: WO 03/020209 (2003-03-01), None
Silverman, The Organic Chemistry of Drug Design and Drug Action (1992) pp. 352-357.
Goodman and Gilman's “The Pharmacological Basis of Therapeutics”, 8th ed. (1990) pp. 13-18.
Montagna et al., Journal of Anatomy, v. 89, 1955 pp. 425-429.
Roberts et al.,, “Skin Transport”, Dermatological and Transdermal Formulation. Drugs and the Pharmaceutical Sciences, Marcel Dekker US, 119, 89-195, 2002.
Khazaei et al., “A novel synthesis and characterization of poly[4-imino(N-4-ethylbenzoate)benzene p-styrenesulphonate] and the investigation on polymer ability for drug release”, Iranian Polymer Journal, 10(1), 59-65, 2001.
Malhotra et al:, “Percutaneous Absorption and Pharmacokinetics of Eflornithine HCI 13.9% Cream in Women with Unwanted Facial Hair”, J. Clin. Pharmacol. 41, 972-978, 2001.
Beisson et al., “Use of the Tape Stripping Technique for Directly Quantifying Esterase Activities in Human Stratum”, Corneum. Anal. Biochem, 290, 179-185, 2001.
Shander et.al., “Clinical dose range studies with topical application of the ornithine decarboxylase inhibitor eflornithline HCI (a-difluoromethyl-dl-ornithine; DFMO) in women with facial hirsutism”, Abstract # P 123, American Academy of Dermatology 59th Annual Meeting, 2001.
Schrode et,al., “Randomized, double-blind, vehicle-controlled safety and efficacy evaluation of eflornithine 15% cream in the treatment of women with excessive facial hair”, Abstract # P291, Americal Academy of Dermatology 58th Annual Meeting, 2000.
Huber, et,al., “Use of a video imaging system to obtain hair measurement data in controlled clinical trials evaluating the safety and efficacy of eflornithine 15% cream in the treatment of excessive facial hair in women”, Abstract # P292, Americal Academy of Dermatology 58th Annual Meeting, 2000.
Huber, “Outcome of a quality of life assessment used in clinical trials for hirsute women treated with topical eflornithine 15% cream”, Abstract # P293, Americal Academy of Dermatology 58th Annual Meeting, 2000.
Botchkatev et al., “A New Role for Neurotrophin-3”,American Journal of Pathology, vol. 153, pp. 785-799, 1998.
Botchkarev et al., “Neurotrophin-3 Involvement in the Regulation of Hair Follicle Morphogenesis”,The Journal of Investigative Dermatology, vol. 111, No. 2, pp. 279-285, 1998.
Hoffman et al., “Interleukin-1 β-Induced Inhibition of Hair Growth In Vitro Is Mediated by Cyclic AMP”,The Journal of Investigative Dermatology, vol. 108, pp. 40-42, 1997.
Kouzuki et al., “Precutaneous absorption of amino acids. Part 2. Drug Delivery System”, 11(5), 329-335, 1996.
Messenger, Andrew G., “The Control of Hair Growth: An Overview”,The Journal of Investigative Dermatology, vol. 101, No. 1, pp. 4s-9s, 1993.
Weinberg et al., “Reconstitution of Hair Follicle Development In Vitro: Determination of Follicle Formation, Hair Growth, and Hair Quality by Dermal Cells”,The Journal of Investigative Dermatology, vol. 100, pp. 229-236, 1993.
McCann, et al., “Ornithine Decarboxylase as an Enzyme Target for Therapy”, Pharmac. Ther. 54: 195-215, 1992.
Ebling, F. John G., “The Biology of Hair”,Dermatologic Clinics, vol. 5, No. 3, pp. 467-481, 1987.
Danzin et al., “Absence of stereospecificity in the suicide inhibition of ornithine decarboxylase”, In Biochemistry of Vitamin B6, pp. 333-336, 1987.
Hattori et al., “Biochemical Analysis of Hair Growth From the Aspects of Aging and Enzyme Activities”,The Journal of Dermatology, vol. 10, pp. 45-54, 1983.
Metcalf et al., “Catalytic Irreversible Inhibition of Mammalian Ornithine Decarboxylase (E.C.4.1.1.17) by Substrate and Product”, Analogues. J. of the American Chemical Society. 100:2551-2553, 1978.
Adachi et al., “Human Hair Follicles: Metabolism and Control Mechanisms”,Journal of the Society of Cosmetic Chemists, vol. 21, No. 13, pp. 901-924, 1970.
Sato, Yoshio, “The Hair Cycle and Its Control Mechanism”, pp. 3-13, 1976.
Bey et.al. “Direct Synthesis of a-Halogenomethyl-a-amino acids from the parent a-amino acids”, J. Org. Chem., 44: 2732-2742, 1979.

Affiliated with

Also associated with

Rating

Reduction of hair growth does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Reduction of hair growth, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Reduction of hair growth will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3934224